High proliferative-potential colony-forming cells (HPP-CFC
ing stem Thus, murine HPP-CFC represent a heterogeneous population of primitive progenitors.
The resolution of murine HPP-CFC populations based on their growth factor needs has demonstrated that the most primitive progenitors, progenitors with the greatest proliferative capacity, require multiple cytokines for In contrast, more mature progenitors are able to proliferate in response to stimulation by a single cytokme. The unresponsiveness of early progenitors to single cytokines may constitute a regulatory mechanism whereby individual cytolunes stimulate the growth of sEecific lineage committed progenitors without also stimulating the entire stem cell pool.
Normal human BM and BM obtained from cancer patients undergoing chemotherapy with 5-FU was shown by McNiece et all' to contain HPP-CFC, thus suggesting that a population, analogous to murine HPP-CFC, of primitive progenitors with an extensive in vitro proliferative capacity is also present in human BM. A proportion of the human HPP-CFC exhibited a synergistic growth response to the cytokine combination granulocyte-macrophage colony-stimulating factor (GM-CSF) + interleukin-3 (IL-3)." However, the addition of a number of other growth factors did not increase the growth of human HPP-CFC above the numbers detected with GM-CSF + IL-3." The utility of the human HPP-CFC assay as ;L measure of primitive progenitorktem cell activity still remains speculative and is based on analogies with the murine system. The development of the human hematopoietic system has been shown to begin in the yolk sac of fetuses at 4 weeks of gestation. At 5 weeks of gestation hematopoiesis starts to shift from the yolk sac to the fetal liver (FL)." The FL is the predominant site of hematopoiesis in the fetus until the development of the BM. The FL is highly erythrop~ieticl~ but also contains myeloid".'6 and lymphoidI7 precursors. In this study we show the presence of a population of HPP-CFC in the human FL. Through the use of fluorescenceactivated cell sorting (FACS) we have characterized these FL HPP-CFC to be predominantly CD34' CD33' CD38 and heterogeneous for HLA-DR expression. olis, MN) and were used at 20 ng/mL. rhGM-CSF and rhL-6, used at 10 nglmL, were produced at our institute and were kindly provided to us by Dr Robert Kastelein.
MATERIALS AND METHODS

Cytokines
The following unconjugated, biotinylated, phycoerythrin (PE)-labeled, fluorescein isothiocyanate (FITC)-labeled, or tricolor (TC)-labeled monoclonal antibodies (MoAbs) were purchased from Becton Dickinson (San Jose, CA) or an otherwise stated vendor: Mouse IgGI-PE, mouse IgG2a-PE, mouse IgG1-FITC, mouse IgG2a-FIX Mouse IgGI-TC (Caltag Laboratories, South San Francisco, CA); mouse IgG2a-TC (Caltag); CD3 (SK7). CD3-PE (SK7), CD3-FITC (SK7), CD7-PE (CD7-6B7) (Caltag); CDlO-PE (5-1B4) (Caltag); CD13-PE (WM-47) (Dako, Glosbup, Denmark); CD14 (M0P9), CD14-PE (M0P9), CD16-PE (B73.1). CD19 (4G7), CD19-PE (4G7), CD20 (L27), CD20-PE (L27), CD33-PE (P67.6), CD33-TC (251) (Caltag); CD34-biotin (8G12), CD34-PE (8G12), CD34-FITC (8G12), CD38-PE (HB-7), CD38-FITC (HIT2) (Caltag); CD45RO-PE (UCHL-l), CD45RA-FITC (L48), CD56 (MY31), CD56-PE (MY31), CD7 I-FITC (LO1 .l), HLA-DR-PE (L243), HLA-DR-TC (HL38) (Caltag); anti-glycophorin A (GPA) (IOF7MN, obtained from American Type Culture Collection [ATCC], Rockville, MD); ckit-PE (17F1 l ) (AMAC Inc, Westbrook, ME); and Thy-l-PE (5E10) (PharMingen, San Diego, CA). Allophycocyanin (APC)-labeled streptavidin was also purchased from Becton Dickinson and TClabeled streptavidin was purchased from Caltag.
Human FL. Human FL, gestational ages from 16 to 21 weeks, were obtained from Advanced Bioscience Resources (Alameda, CA) and were used with the approval of the Committee for the Protection of Human Subjects at our institute. The gestational age of the abortuses was approximated by the crown-rump method.
FL progenitor isolation. A single FL was used in each experiment. Fetal livers were homogenized through a wire mesh and washed once by centrifugation in phosphate-buffered saline (PBS) containing 2% fetal bovine serum (FBS) (JRH Biosciences, Lenexa, KS) and 50 pg/mL gentamicin (GIBCO, Grand Island, NY). Washed FL cells were resuspended in a 1.085 g/mL solution of saline buffered Accudenz (Accurate Chemical & Scientific Corp. Westbury, NY) and light density fetal liver (LDFL) cells were isolated after 25 minutes of centrifugation at 1,OOOg. After density centrifugation LDFL cells were maintained on ice or at 4°C throughout the subsequent isolation procedures. LDFL cells were depleted of erythroid cells by labeling with a saturating amount of anti-GPA MoAb followed by a 15-minute magnetic-bead depletion with sheep antimouse IgG-coated Dynabeads (Dynal Inc, Great Neck, NY). In all experiments in which LDFL cells were labeled with MoAb, the cells were first preincubated for 10 minutes in a solution of PBS supplemented with I mmol/L EDTA, 50 pg/mL gentamicin, 0.5% human gamma globulins (Sigma Chemical CO, St Louis, MO), and 2% normal mouse serum followed by staining with MoAb for at least 30 minutes in the same solution.
In some initial experiments GPA-LDFL cells were enriched for CD34' cells by panning using anti-CD34 antibody-coated tissue culture flasks (Applied Immune Sciences, Menlo Park, CA) as described by the manufacturer. In subsequent experiments GPA-LDFL cells were fractionated based on cell-surface antigen expression by FACS. In preparation for cell sorting, GPA-LDFL cells were depleted immunomagnetically of lineage-committed progenitors and mature hematopoietic cells with MoAbs detailed in the Results section. The MoAb-labeled cells were resuspended in PBS containing 2% FBS and 50 pg/mL gentamicin for FACS. During cell sorting the FL cells were kept at 4°C and were collected in 24-well tissue culture plates in 0.5 mL FBS kept at 4°C. Whenever sufficient cell numbers were recovered after cell sorting, reanalysis of the sorted FL cell population was performed and the efficiency of the sorting calculated. Sorting efficiencies typically exceeded 98% purity.
Phenotypic analysis. The expression of cell surface antigens was determined by two-color cytofluorimetry using a FACScan (Becton Dickinson). GPA-LDFL cells (1 x los) were stained with labeled
MoAbs for 30 minutes. After staining the cells were washed twice in PBS containing 0.5% bovine serum albumin and 0.05% NaN3 followed by FACScan analysis. Colony-fonning unit culture (CFU-C) assay. Myeloid progenitors were assayed in double-layered clonal cultures in 60-X 15-mm tissue culture dishes (Becton Dickinson).2,'s The FL cells were grown in culture medium comprised of Iscove's modified Dulbecco's medium (IMDM) (Sigma) supplemented with 20% FBS, 50 p g h L gentamicin, and 7.5 X lo-' m o m a-thioglycerol (Sigma). The double-layered cultures consisted of a 2-mL bottom layer containing culture medium, cytokines, and 0.5% SeaPlaque agarose (FMC, Rockland, ME). The upper layer of the clonal cultures contained the FL cells suspended in culture medium and 0.36% agarose. The number of FL cells plated is indicated in the figure legends. Cultures of FL cells were incubated for 3 weeks, unless a different culture period is indicated, at 37°C in a fully humidified atmosphere supplemented with 5% CO,.18 Cultures were scored for the presence of HPP-CFC, and defined as precursors that gave rise to colonies greater than 0.5 mm in diameter using the criteria defined by Bradley and Hodgson.' The clonal cultures were also scored for low-proliferative potential CFC (LPP-CFC), colonies smaller than HPP-CFC but greater than 50 cellskolony. The number of cells/HPP-CFC colony were determined as previously described."
For the photographing of colonies in tissue culture dishes, the cultures were stained as previously Data presentation and statistical analysis. Unless otherwise stated, the data from multiple experiments were pooled and are presented as the median 2 median absolute deviation to reduce the effect of outliers. Statistical significance was determined on individual experiments (single tissues) using the two-tailed paired Student's t-test. Statistical significance of data obtained from multiple experiments was calculated using nonparametric Wilcoxon signed rank test. Differences in the data were considered significant when P S: .05. (Fig 1) . The combination of IL-3 + GM-CSF was used as the standard stimulus for HPP-CFC growth in all the subsequent experiments, unless otherwise indicated, to provide consistency with the studies on adult human BM The optimum period of time required for the development of HPP-CFC in clonal cultures of CD34' LDFL cells was determined by analyzing the number and size of HPP-CFC at weekly intervals (Fig 2) . The greatest number of colonies was detected after 3 weeks of growth. The number of HPP-CFC continued to increase between 3 and 4 weeks of incubation, whereas the number of LPP-CFC began to decrease during this time period (Fig 2A) . The median number of cells/HPP-CFC colony also continued to increase from 4.3 X lo4 cells to 8.3 X 10'' cellskolony between 3 and 4 weeks of culture (Fig 2B) . Colonies judged to be derived from HPP-CFC2 were very heterogeneous in cellularity ranging from 2.5 X 10" cells to 7.4 X 10' cellskolony. Three weeks was chosen as the standard incubation period for FL myeloid colonies because the maximum number of CFU-C was detected at this time.
RESULTS
Human
HPP-CFC reside predominantly in the CD34+ CD38-lineage-fraction of LDFL cells. The expression of CD34, CD38, CD33, and HLA-DR on FL HPP-CFC was characterized by two-color FACS. Before cell sorting, LDFL cells were depleted with magnetic beads of GPA+ CD3' CD14' CD19' CD20+ and CD56' cells. This lineage depleted ( h -) subset of FL cells was further sorted into six populations by gating on cells positive for CD34-FITC expression and either positive or negative for CD38-PE, CD33-PE, or HLA-DR-PE expression. The CD34+ CD38-lin-LDFL cell subset HPP-CFC.~~ contained a sevenfold greater number of primary HPP-CFC than observed in the CD34' CD38' lin-LDFL cell fraction (P S .02 in four of five experiments) ( Fig 3A) . The numbers of secondary HPP-CFC generated after 7 days of growth in A-cultures were 82-fold greater in cultures of CD38-cells than in cultures of CD38+ cells (P S .02 in three of four experiments) (Fig 3B) . Furthermore, the numbers of secondary HPP-CFC were increased 15-fold over input values in A-cultures of CD38-FL cells, demonstrating a greater proliferative capacity of CD38-cells compared with the CD38' fraction of FL cells. Equivalent numbers of HPP-CFC were recovered before and after A-culturing of CD38+ cells ( Fig  3C) . The CD34' CD33' lin-LDFL cell fraction contained both HPP-CFC and progenitors giving rise to secondary HPP-CFC after growth in A-cultures. The recovery of CD34+ CD33-lin-LDFL cells was variable and sufficient numbers of cells for analysis were not always recovered. However, in two of three experiments the numbers of primary and secondary HPP-CFC measured from cultures of CD33-cells were significantly fewer than in cultures of CD33' cells (P S .04) (Fig 3, A and B) . Separation of CD34' lin-LDFL cells based on HLA-DR expression resulted in HLA-DR+ and HLA-DR-populations that had equivalent HPP-CFC activity and proliferative capacity in the A-assay. These results show that the bulk of human FL HPP-CFC are contained in the CD38-fraction of CD34' lin-LDFL cells. Therefore, the CD38-fraction of FL cells was used for the further purification of HPP-CFC.
Phenotypic analysis of CD38 expression by human FL cells. The expression of CD38 and other cell-surface antigens by GPA-LDFL cells was analyzed to better define the expression of CD38 by FL progenitors and the expression of lineage markers by CD38-cells (Fig 4) . The histogram of CD38-FITC expression by GPA-LDFL cells, gated for low side scatter, showed two subsets of CD38+ cells, a CD38dU" subset and a CD38h"gh' subset. A third population, representing less than 15% of the gated GPA-LDFL cells, was CD38-. The CD38'ngh' fraction contained cells that stained with MoAbs against the CD3, CD7, CDIO, CD14, CD16, CD19, CD20, CDS6. and HLA-DR antigens. The CD38d"" population was comprised of CD3', CD7', CD14'. CD33', C D W , CD56', and HLA-DR' cells. Expression of the CD3, CD7, CD14, CD33, CD34, CDS6, and HLA-DR antigens was also observed among the CD38-fraction of GPA-LDFL cells. CD38 was found to be expressed on 61 96 to 74% of CD33' cells, on 82% to 89% of HLA-DR' cells, and on 67% to 75% of CD34' cells (n = 3 to 4 experiments).
The intensity of CD34 expression has been shown to decrease with the maturation of hematopoietic progenitors." Thus, it is of interest to note that the lowest level of CD38 expression was observed on cells expressing the highest levels of CD34. CD34' CD38-lin-LDFL cells are heterogeneous for HLA-DR expression. The expression of HLA-DR on progenitors contained within the CD34' CD38-lin-fraction of LDFL cells was determined using three-color FACScan analysis. The CD34' CD38-lin-population represents and the HLA-DR' fractions were isolated and HPP-CFC activity accessed.
The numbers of primary and secondary HPP-CFC and LPP-CFC in the HLA-DR-and the HLA-DR" fractions of CD34' CD38-lin-LDFL cells were equivalent (Fig 6) . These data confirm the results shown in Fig 3 in which similar proliferative potentials were observed among the HLA-DR' and HLA-DR-subsets of CD34' lin-LDFL cells.
For CD34+ CD38-lin-LDFL cells are predominantly CD33'. The presence of HPP-CFC among the CD33' and CD33-subsets of the CD34' CD38-lin-LDFL cell fraction was investigated using three-color FACS. In three experiments CD33-cells were observed to be rare among CD34' CD38-lin-LDFL cells (data not shown). In one of these experiments CD33-cells were isolated and no primary HPP-CFC or LPP-CFC were detected, whereas in all three experiments a median of 12.4 HPP-CFC and 21.3 LPP-CFC/1 X lo3 CD34' CD33+ CD38-lin-LDFL cells were detected. The expression of CD33 and HLA-DR on CD34+ CD38-lin-LDFL cells is shown in Fig 7. The data show that 1.6% of the CD34+ CD38-lin-LDFL cells were CD33-and these cells were found almost exclusively in the HLA-DRfraction. CD33+ cells constituted 98.4% of the CD34' CD38-lin-LDFL cell fraction.
Using two methods of purification we attempted to isolate and measure progenitor activity from CD34+ CD33-HLA-DR-CD38-lin-LDFL cells (Fig 8) . The isolation of FL cells based on the lack of staining with CD33-PE (purification A) or CD33-TC (purification B) resulted in less than . The differences between the numbers of HPP-CFC and LPP-CFC observed in the CD33' and CD33-groups were signihcant using both purification methods (Wilcoxon signed rank test, P < .05). Thus, most of the HPP-CFC and LPP-CFC activity detected in the FL can be attributed to CD33' cells and the little CFU-C activity measured in the CD33-fraction could have resulted from the contamination of the CD33-fraction by CD33+ cells. Phenotypic analysis of CD34' CD38-lin-LDFL cells. The observation that almost all of the hematopoietic progenitor activity in the CD34' CD38-lin-LDFL cell fraction is found in the CD33' subset suggests that stem cells may express CD33. This hypothesis is in contradiction to the generally held belief that CD33 is expressed only on myeloid-committed progenitors. Therefore, we investigated the expression of additional cell surface antigens previously used in the delineation of eariy progenitors and stem cells. No expression of CD45RO was observed on CD34+ GPA-LDFL cells (Fig 9) and CD34' CD38-lin-LDFL cells (data not shown). GPA-LDFL cells expressing the highest levels of CD34, of which only a small fraction are CD38-, could be discriminated based on the expression of CD45RA and CD71 (transferrin receptor) (Fig 9) . However, in a threecolor analysis greater than 92% of CD34' CD38-lin-LDFL cells were negative for the expression of CD45RA and CD7 I . Both c-kit' (CD1 17) and c-kit-subpopulations were observed among CD34' GPA-LDFL cells and CD34+ CD38-lin-LDFL cells. Although c-kit expression was high on CD34br'Sh' cells, considerable variability in the expression of c-kit on CD34' CD38-lin-LDFL cells was seen. The percentage of c-kit' cells among CD34' CD38-lin-LDFL cells ranged from 26% to 90% (n = 3). A low level of Thy-1 (CDw90) expression was present on a subpopulation of CD34' GPA-LDFL cells, whereas Thy-1' cells were enriched (73%) among CD34+ CD38-lin-LDFL cells. Furthermore, a comparison of Thy-l and CD38 expression on CD34b"gh' lin-LDFL cells showed a reciprocal regulation of CD38 and Thy-l expression: Thy-l was expressed on cells with the lowest levels of CD38 expression (CD38-and CD38d""), whereas on CD34hr'gh' lin-LDFL cells with the highest level of CD38 expression, Thy-l was no longer expressed (data not shown). CD13 (aminopeptidase N) was expressed on CD34+ GPA-LDFL cells and CD34' CD38-lin-LDFL cells. Thus, these results show that CD34+ CD33+ CD38-lin-LDFL cells can be further characterized as CD1 3+ CD45RO-CD45RA-CD7 1 and heterogeneous for Thy-I , c-kit, and HLA-DR expression. diverse is the compartment of progenitors detected in the HPP-CFC assay and does the HPP-CFC assay detect stem cells. To address these questions we used primary clonal cultures and the A-assay to characterize the proliferative capacities of FL HPP-CFC subsets defined by their expression of HLA-DR, CD33, and CD38.
FL HPP-CFC are CD34' CD38-. Human hematopoietic progenitor cells obtained from various tissues express CD34?"*' Hematopoietic cells with the highest level of CD34 expression have also been further subdivided based on CD38 expression. Terstappen et a12' showed that CD34' CD38-BM cells, when seeded on BM stroma, gave rise to sustained hematopoiesis whereas, CD34' CD38' cells contained progenitors with a limited proliferative capacity. Likewise, Issaad et a12* recently confirmed these results and further showed that adult human BM HPP-CFC activity could be found among CD34' CD38-cells. In this study we extend these results by demonstrating that the bulk of FL HPP-CFC activity could be found in the population of 3177 CD34' CD38-lin-LDFL cells. Although some HPP-CFC were observed in the CD38' fraction of FL cells. the proliferative capacity of these cells was diminished IS-fold relative to progenitors in the CD38-fraction as measured in the Aassay. Thus, the acquisition of cell surface CD38 by FL progenitors coincides closely with the differentiation of progenitors from HPP-CFC to LPP-CFC.
FL HPP-CFC are heterogeneous for HLA-DR e.xpression. We further characterized FL HPP-CFC by depleting of CD38' cells in our FACS protocol. Analysis of HLA-DR expression by CD34' CD38-lin-LDFL cells showed that greater than 75% of these cells express high levels of HLA-DR, whereas the remainder of CD34' CD38-lin-LDFL cells express intermediate levels or no HLA-DR. Colony formation by the HLA-DR' and HLA-DR-subpopulations of CD34' CD38-lin-LDFL cells showed that these two subpopulations have similar frequencies of HPP-CFC and LPP-CFC. Furthermore, the proliferative potential of HLA-DR' and HLA-DR-cells was similar in the A-assay. Thus, no functional differences between HLA-DR' and HLA-DR-FL cells were observed using the HPP-CFC assay and the A-assay.
The presence of HLA-DR on human committed and multipotential progenitors has been shown in a number of studies using complement depletion or FACS.'"'Z5 These studies demonstrated that most myeloid and erythroid progenitors were HLA-DR'. Furthermore. Huang and Terstappen" have shown that 93% of CD34' fetal BM cells were HLA-DR'. However, in contrast to our results with FL cells, these investigators observed that equivalent numbers of CD34' CD38-fetal BM cells were HLA-DR' and HLA-DR-. This difference may be caused in part by our depletion of FL cells expressing lineage markers. Alternatively, FL progenitors within the CD34' CD38-compartment may contain relatively fewer numbers of HLA-DR-cells than found in the fetal BM.
Although most progenitors express HLA-DR. a number of studies provide evidence suggesting that early progenitors/ stem cells are HLA-DR-. Moore et al" were the first to show that progenitors capable of extensive proliferation in vitro when seeded on an established BM stromal layer were resistant to killing by complement and anti-HLA-DR serum. This finding was confirmed by others.>' Verfaillie et d 9 further demonstrated that lineage-depleted CD34' HLA-DR-BM progenitors could adhere to BM stromal cells, whereas lineage-depleted CD34' HLA-DR' progenitors did not share this adhesive property. In our study we were unable to show substantial differences in proliferative capacity between HLA-DR.. and HLA-DR' progenitors. suggesting that cultures containing GM-CSF + IL-3 do not provide the growth sustaining environment provided by the BM stroma. HLA-DR-progenitors have also been shown to be insensitive to the inhibitory effects of prostaglandin E" and acidic isofemtins,4(1 in contrast to HLA-DR' progenitors. The insensitivity of HLA-DR-cells to killing by tritiated thymidine has also been reported,J" suggesting that HLA-DR-progenitors are not actively cycling in contrast to HLA-DR' progenitors. A quiescent cell cycle status has been shown to be a property of murine stem cells.' However, the expression of In total these studies suggest that the HLA-DR-subset of hematopoietic cells differ from the HLA-DR' subset in that the HLA-DR-subset contains pluripotential high proliferative-potential progenitors, and thus stem cells probably reside in the HLA-DR-subset. However, our data show that the clonal and suspension culture assays used in this study cannot detect any differences in proliferative-potential between the HLA-DR-and HLA-DR' subsets of CD34' CD38-LDFL cells. FL HPP-CFC w e CD33' CD13'. Almost all of the CFU-C that we detected in the FL were CD33'. Phenotypic analysis of CD34' CD38-lin-cells showed that less than 2% of these cells were CD33-and most of these CD3T cells were also HLA-DR-. The bulk of HPP-CFC and LPP-CFC activity was found among the CD33' fraction. These results are in agreement with previous studies demonstrating that most CFU-C activity found in the adult BM was associated with CD33' However, CD34' CD33-cells were observed by Andrews et all3 and La Russa et alJ5 to contain progenitors capable of extensive proliferation in long-term BM cultures when seeded on established BM stromal layers. Autologous BM transplantation of leukemic patients with BM depleted of CD33' cells by complement depletion resulted in a slow but sustained hematopoietic reconstitution.Jh Therefore, these studies suggest that some hematopoietic stem cells are contained in the CD33-fraction of the BM and the growth of CD.33-progenitors requires factors provided by the BM stroma. However, Litzow et alJ7 observed that the cytokine combination of IL-3 + G-CSF was synergistic in stimulating the growth of BM CD33-progenitors, whereas CD33' progenitors did not require stimulation by multiple cytokines for gr~wth.~' Similarly. Smith et al"' observed synergism between IL-I and IL-3 in stimulating the growth of CD34' CD33-CD1 lb-soybean For personal use only. on May 30, 2017. by guest www.bloodjournal.org From agglutinin-BM cells in A-cultures, whereas this cell population gave rise to few colonies in clonal cultures. Thus, combinations of cytokines can stimulate the growth of some BM CD34' CD33-progenitors in the absence of a BM stroma. In this study we did not observe any obvious growth by CD34' CD33-HLA-DR-CD38-lin-LDFL cells in response to either IL-3 + GM-CSF or IL-3 + IL-6 + GM-CSF + KL. However, these cytokine combinations may be insufficient in promoting the growth of FL stem cells. Thus, it remains to be determined whether the CD34+ CD33-HLA-DR-CD38-lin-LDFL cell population contains progenitors and/or stem cells despite the lack of significant HPP-CFC and LPP-CFC activity. Alternatively, FL stem cells may express CD33 and thus be contained in the CD34' CD38-fraction of FL cells in which HPP-CFC activity was detected.
CD 13, like CD33, is expressed on myeloid progenitor^.^^ Therefore, we examined the expression of CD13 on FL progenitors with the hope of further resolving myeloid-committed progenitors and stem cells. However, we observed that CD13 was expressed by all CD34' CD38-lit" LDFL cells. The expression of CD13 has been reported on B cells49 and T cells,5o as well as leukemias of multiple lineage^.^' Thus, CD13 may be expressed on FL stem cells.
CD34' CD38-lin-LDFL cells have a phenotype associated with stem cells. The cell-surface markers CD45R0, CD45RA, CD71, Thy-l (CDw90), and c-kit (CD1 17) have been used by a number of investigators in the phenotypic characterization of hematopoietic progenitors and stem cells. Analysis of the expression of these markers by CD34' CD38-lin-LDFL cells showed that the bulk of these cells were CD45RO-CD45RA-and CD71-. These results help to confirm that the CD34' CD33' CD38-lin-LDFL population, containing HPP-CFC, does contain early progenitors, because it has been shown that CD45RA and CD71 are not expressed or are expressed at low levels on early hematopoietic
The lack of CD45RO expression on CD34' FL cells observed in this study is in agreement with the reported results of Fritsch et a1: ' who also failed to observe consistent CD45RO expression by BM, peripheral blood, and cord blood progenitors. However, Lansdorp et a1" did demonstrate the expression of CD45RO on early BM progenitors. The reason for this discrepancy in CD45RO expression on CD34' cells is not apparent. We also observed the expression of Thy-l on most of the CD34+ CD38-lin-LDFL cells as well as on some CD34' CD38+ lin-LDFL cells. Thy-l has been shown to be expressed by adult BM HPP-CFCS4 and multipotent progenitor^.'^ Thus, the low expression of Thy-l by CD34+ CD38-lin-LDFL cells suggests that some HPP-CFC are pluripotent stem cells. Heterogeneity in c-kit expression was observed among CD34' lin-LDFL cells. Overall c-kit expression increased with increased CD34 expression, although c-kit-cells were observed among CD34' CD38-lin-LDFL cells. The functional significance of heterogeneous c-kit expression is not known; however, the ability of KL to promote the growth of FL HPP-CFC in combination with other cytokines suggests that the expression of its receptor, c-kit, is important in the regulation of early FL progenitors. Progenitors capable of myeloid and/or erythroid differentiation have been shown to be enriched among the c-kit' fractions of FL, cord blood, BM, and peripheral blood ~e l l s .~~,~' The relationship between c-kit expression on CD34+ CD38-lin-LDFL cells and the functional capabilities of these cells is under investigation.
In conclusion, the human FL contains a compartment of myeloid progenitors that are capable of extensive proliferation in vitro. A high proliferative capacity is a hallmark of stem cells and the extensive characterizations of murine HPP-CFC suggest that HPP-CFC are a compartment of progenitors that probably contains stem cells.' Human FL HPP-CFC are predominantly found among CD34' CD33' CD13' CD38-CD45RO-CD45RA-CD71-lin-LDFL cells. Thyl expressing cells were also found to be enriched among the population of FL cells containing HPP-CFC. The expression of HLA-DR was heterogeneous on FL HPP-CFC. Thus, FL HPP-CFC represent a compartment of early myeloid precursors and their relationship to stem cells is at the present not clear. To further understand the ability of the FL HPP-CFC compartment to undergo multilineage differentiation, we are currently investigating the presence of lymphoid progenitors among FL cell populations capable of giving rise to HPP-CFC. Our inability to detect HPP-CFC in a putative stem cell compartment defined as CD34+ CD33-HLA-DR-CD38-lin-suggests that this phenotypic profile may not define FL stem cells. Although we have not shown stem cell activity from the CD34+ CD38-lin-LDFL cell fraction, further analysis is warranted because the number of stem cells in the FL is of clinical relevance. The FL has been used as a source of transplantable stem cells with success in reconstituting the lymphoid57 and myeloid5' compartments; however, the incidence of engraftment is relatively low, possibly because of the limited number of progenitors transplanted.
